Literature DB >> 16840480

Communicating information about drug safety.

R E Ferner1, J K Aronson.   

Abstract

Mesh：

Year:  2006        PMID： 16840480      PMCID： PMC1502200          DOI： 10.1136/bmj.333.7559.143

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Adverse drug reactions: keeping up to date.

Authors:  Jeffrey K Aronson; Sheena Derry; Yoon K Loke
Journal:  Fundam Clin Pharmacol       Date:  2002-02       Impact factor: 2.748

Review 2.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

3.  Computer aided prescribing leaves holes in the safety net.

Authors:  R E Ferner
Journal:  BMJ       Date:  2004-05-15

4.  Classifying drug interactions.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

Review 5.  Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.

Authors:  Yoon Kong Loke; Deirdre Price; Sheena Derry; Jeffrey K Aronson
Journal:  BMJ       Date:  2006-01-18

Review 6.  Cyclooxygenase-2 inhibitors.

Authors:  Christopher J Hawkey; Paul J Fortun
Journal:  Curr Opin Gastroenterol       Date:  2005-11       Impact factor: 3.287

7.  Physicians' decisions to override computerized drug alerts in primary care.

Authors:  Saul N Weingart; Maria Toth; Daniel Z Sands; Mark D Aronson; Roger B Davis; Russell S Phillips
Journal:  Arch Intern Med       Date:  2003-11-24
  7 in total
  17 in total

1.  Risk perception in drug therapy.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

2.  An agenda for research on adverse drug reactions.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2007-08       Impact factor: 4.335

3.  On pharmaceutical risk minimization.

Authors:  Torbjörn Callréus
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

4.  The science of prescribing.

Authors:  Derek G Waller
Journal:  Br J Clin Pharmacol       Date:  2012-10       Impact factor: 4.335

5.  The Burden of Polypharmacy in Patients Near the End of Life.

Authors:  Michael J McNeil; Arif H Kamal; Jean S Kutner; Christine S Ritchie; Amy P Abernethy
Journal:  J Pain Symptom Manage       Date:  2015-09-30       Impact factor: 3.612

Review 6.  Antidiabetic medications and polypharmacy.

Authors:  Emily P Peron; Kelechi C Ogbonna; Krista L Donohoe
Journal:  Clin Geriatr Med       Date:  2014-10-16       Impact factor: 3.076

7.  Is the Internet replacing health professionals? A population survey on sources of medicines information among people with mental disorders.

Authors:  Marika Pohjanoksa-Mäntylä; J Simon Bell; Satu Helakorpi; Ulla Närhi; Anne Pelkonen; Marja S Airaksinen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-03-12       Impact factor: 4.328

8.  Probable sarcopenia: associations with common geriatric syndromes and comorbidities in Turkish geriatric patients from a university hospital.

Authors:  Duygu Erbas Sacar; Cihan Kılıc; Meryem Merve Oren; Tugba Erdogan; Serdar Ozkok; Caglar Ozer Aydın; Nezahat Muge Catikkas; Mehmet Akif Karan; Gulistan Bahat
Journal:  Eur Geriatr Med       Date:  2022-08-27       Impact factor: 3.269

Review 9.  CNS adverse events associated with antiepileptic drugs.

Authors:  Gina M Kennedy; Samden D Lhatoo
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 10.  Polytherapy and drug interactions in elderly.

Authors:  Hima Bindu Gujjarlamudi
Journal:  J Midlife Health       Date:  2016 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.